The Achilles’ heel of hepatocellular carcinoma: ginsenoside compound K as a novel GPX4 degrader promotes ferroptosis in hepatocellular carcinoma | Synapse
March 3, 2026Open Access
The Achilles’ heel of hepatocellular carcinoma: ginsenoside compound K as a novel GPX4 degrader promotes ferroptosis in hepatocellular carcinoma
Key Points
Ginsenoside compound K significantly promotes ferroptosis, enhancing tumor cell death.
Ferroptosis induced by compound K is linked to decreased GPX4 protein levels, resulting in oxidative stress.
Assessment using biochemical assays shows marked inhibition of hepatocellular carcinoma cell growth.
This novel intervention suggests therapeutic potential for hepatocellular carcinoma treatment.